拨康视云-B(02592.HK)向服务供应商参与者Whitcup Life Sciences授出500万份受限制股份单位

Core Viewpoint - The company announced a grant of restricted share units under its post-IPO equity incentive plan, which requires acceptance from the grantees to become effective [1] Group 1 - The company will grant 5 million restricted share units to Whitcup Life Sciences LLC, a service provider involved in R&D and business development services [1] - The grant to Whitcup Life Sciences LLC represents more than 0.1% of the company's total issued shares as of the grant date [1] - Whitcup Life Sciences LLC is wholly owned by Dr. Scott Whitcup, who serves as the chairman of the company's scientific advisory committee [1]